220 related articles for article (PubMed ID: 30106451)
1. Association between Tim‑3 and Gal‑9 expression and gastric cancer prognosis.
Wang Y; Zhao E; Zhang Z; Zhao G; Cao H
Oncol Rep; 2018 Oct; 40(4):2115-2126. PubMed ID: 30106451
[TBL] [Abstract][Full Text] [Related]
2. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema.
Fernandez-Santamaría R; Palomares F; Salas M; Doña I; Bogas G; Ariza A; Rodriguez-Nogales A; Plaza-Seron MC; Mayorga C; Torres MJ; Fernández TD
Allergy; 2019 Sep; 74(9):1769-1779. PubMed ID: 31034608
[TBL] [Abstract][Full Text] [Related]
4. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.
Kandel S; Adhikary P; Li G; Cheng K
Cancer Lett; 2021 Jul; 510():67-78. PubMed ID: 33895262
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract][Full Text] [Related]
6. CD8
Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
[TBL] [Abstract][Full Text] [Related]
7. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
[No Abstract] [Full Text] [Related]
8. Prediction of the Peptide-TIM3 Binding Site in Inhibiting TIM3-Galectin 9 Binding Pathways.
Odstrcil RE; Dutta P; Liu J
J Chem Theory Comput; 2023 Sep; 19(18):6500-6509. PubMed ID: 37649156
[TBL] [Abstract][Full Text] [Related]
9. Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.
van Esch EM; van Poelgeest MI; Kouwenberg S; Osse EM; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
Int J Cancer; 2015 Feb; 136(4):E95-106. PubMed ID: 25220367
[TBL] [Abstract][Full Text] [Related]
10. TIM3
Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R
Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458
[TBL] [Abstract][Full Text] [Related]
11. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma: the significance of CD8
Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
[TBL] [Abstract][Full Text] [Related]
13. The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis.
Sada-Ovalle I; Chávez-Galán L; Torre-Bouscoulet L; Nava-Gamiño L; Barrera L; Jayaraman P; Torres-Rojas M; Salazar-Lezama MA; Behar SM
J Immunol; 2012 Dec; 189(12):5896-902. PubMed ID: 23180819
[TBL] [Abstract][Full Text] [Related]
14. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
15. Tim3 binding to galectin-9 stimulates antimicrobial immunity.
Jayaraman P; Sada-Ovalle I; Beladi S; Anderson AC; Dardalhon V; Hotta C; Kuchroo VK; Behar SM
J Exp Med; 2010 Oct; 207(11):2343-54. PubMed ID: 20937702
[TBL] [Abstract][Full Text] [Related]
16. Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes.
Sun L; Zou S; Ding S; Du X; Shen Y; Liu C; Shi B; Zhang X
J Diabetes Res; 2020; 2020():2583257. PubMed ID: 33123595
[TBL] [Abstract][Full Text] [Related]
17. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
[TBL] [Abstract][Full Text] [Related]
18. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
19. The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.
Zhong T; Zhao C; Wang S; Tao D; Ma S; Shou C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):783-792. PubMed ID: 33084973
[TBL] [Abstract][Full Text] [Related]
20. Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status.
Wu J; Lin G; Zhu Y; Zhang H; Shi G; Shen Y; Zhu Y; Dai B; Ye D
Sci Rep; 2017 Aug; 7(1):8869. PubMed ID: 28827755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
